# Non-significant efficacy of icotinib plus pleurodesis in epidermal growth factor receptor positive mutant lung cancer patients after malignant pleural effusion drainage compared to icotinib alone

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/non-significant-efficacy-of-icotinib-plus-pleurodesis-in-epidermal-growth-factor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yunhua Xu,Wangsheng Fang,Bingye Cheng,Shanshan Chen,Linping Gu,Li Zhu,Yan Pan,Zhen Zhou |
| Citations | 2 |
| DOI | 10.21037/jtd.2020.03.49 |
| Fields | Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://jtd.amegroups.com/article/viewFile/37141/pdf |
| OpenAlex ID | https://openalex.org/W3011951891 |
| PMID | 32642157 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Linping Gu](https://scholariq.org/researchers/linping-gu/)

## Paper journal

- [Journal of Thoracic Disease](https://scholariq.org/journals/journal-of-thoracic-disease/)

## Paper primary topic

- [Pleural and Pulmonary Diseases](https://scholariq.org/topics/pleural-and-pulmonary-diseases/)

## Paper topics

- [Pleural and Pulmonary Diseases](https://scholariq.org/topics/pleural-and-pulmonary-diseases/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.